Funding constraints and investor caution, not regulation, are delaying crypto IPOs, according to Cohen & Company Capital Markets’ Christian Lopez.Finance, IPOs, Artificial Intelligence, Exclusive, NewsRead More
You might also be interested in reading Insmed outlines $405M–$425M ARIKAYCE revenue target as brensocatib nears launch and pipeline advances.
